Cargando…
Anxiety and depression in spasmodic dysphonia patients
OBJECTIVE/HYPOTHESIS: Experts used to believe that spasmodic dysphonia (SD) was a psychogenic disorder. Although SD is now established as a neurological disorder, the rates of co-morbid anxiety and depression range from 7.1% to 62%. Our objective was to study the prevalence and risk factors associat...
Autores principales: | Hu, Amanda, Hillel, Al, Zhao, Wei, Meyer, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074012/ https://www.ncbi.nlm.nih.gov/pubmed/30101219 http://dx.doi.org/10.1016/j.wjorl.2018.04.004 |
Ejemplares similares
-
Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update
por: Hyodo, Masamitsu, et al.
Publicado: (2022) -
Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia
por: Heyes, Richard, et al.
Publicado: (2023) -
Spasmodic dysphonia like presentation of stiff person syndrome
por: Rana, Abdul Qayyum, et al.
Publicado: (2014) -
Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
por: Cannito, Michael P, et al.
Publicado: (2008) -
Hyperactive sensorimotor cortex during voice perception in spasmodic dysphonia
por: Kanazawa, Yuji, et al.
Publicado: (2020)